Virtual Reality Training Affects on Motor Functions and Mental Health in Stroke Patients
1 other identifier
interventional
34
1 country
1
Brief Summary
In our study, we tested the hypothesis of the safe effect applicability of motor training in the immersion high-tech polymodal VR system not only on the parameters of balance, gait, and motor status of the patient, but also on his cognitive functions and mental health in patients with a degree of disability no more than 3 points on a scale Rankin.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable stroke
Started Oct 2019
Shorter than P25 for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 27, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 27, 2020
CompletedFirst Submitted
Initial submission to the registry
December 18, 2020
CompletedFirst Posted
Study publicly available on registry
December 23, 2020
CompletedDecember 23, 2020
December 1, 2020
10 months
December 18, 2020
December 22, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Postural stability test (Grail Motekforce)
The subject's ability to remain balanced under four different conditions is evaluated (cm/s).
Change from baseline at 2 weeks
Six-minute walk test (6MWT) (Grail Motekforce)
The 6-minute walk test evaluates how much distance a subject can cover in six minutes (m).
Change from baseline at 2 weeks
Beck Depression Inventory
Measures the severity of depression (0-63; 30-63 scores indicate severe depression)
Change from baseline at 2 weeks
State-Trait Anxiety Inventory
Examines two types of anxiety - state anxiety (anxiety about an event) and trait anxiety (anxiety level as a personal characteristic) with the score range from 20 to 80, where higher scores correspond to greater anxiety
Change from baseline at 2 weeks
Secondary Outcomes (6)
Standing Balance Test
Change from baseline at 2 weeks
Berg Balance Scale
Change from baseline at 2 weeks
Timed Up and Go Test
Change from baseline at 2 weeks
Hauser Ambulation Index
Change from baseline at 2 weeks
Rivermead Activities of Daily Living Scales
Change from baseline at 2 weeks
- +1 more secondary outcomes
Study Arms (1)
Training Group
EXPERIMENTALTraining Group recieved 10 sessions on VR (Grail Motekforce, Netherlands) during two weeks. One session lasted 40 minuties.
Interventions
The training is aimed at improving the functioning of the motor sphere, including balance, gait, and upper limb function, as well as increasing the level of motivation and reducing the level of anxiety and depression. Game applications were selected based on therapeutic tasks of motor recovery.
Eligibility Criteria
You may qualify if:
- with a stroke, transferred at least 2 weeks ago; with no history of neurological or psychiatric disorders; able to maintain an upright posture and walk without support or with minimal support for at least 30 minutes; with stable hemodynamics;
You may not qualify if:
- not having epileptic activity; not having serious ophthalmic disorders; less than 24 scores in MoCA
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health
Moscow, 117997, Russia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marina A Shurupova
Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health
- PRINCIPAL INVESTIGATOR
Alina D Aizenshtein
Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health
- STUDY CHAIR
Galina Ivanova, Prof.
Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health
- PRINCIPAL INVESTIGATOR
Nadezhda L Cherepahina, PhD
Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 18, 2020
First Posted
December 23, 2020
Study Start
October 1, 2019
Primary Completion
July 27, 2020
Study Completion
July 27, 2020
Last Updated
December 23, 2020
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share